Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,806,410
-$879,297 QoQ
Shares Held
241,130
+1.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#555
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. PFE ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,083 | $11,449,729 | |
| 2 | PFE |
Pfizer Inc
This page
|
241,130 | $5,806,410 | |
| 3 | SNY |
Sanofi
|
47,681 | $2,034,071 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,160 | $399,234 | |
| 5 | AMGN |
Amgen Inc
|
530 | $191,923 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,400 | $179,900 | |
| 7 | LLY |
ELI LILLY & Co
|
60 | $71,965 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,054 | $60,731 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,806,410 | 241,130 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,685,707 | 238,095 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $5,684,794 | 228,305 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,774,303 | 226,621 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,715,479 | 194,533 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,779,960 | 188,633 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,118,813 | 117,558 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,874,002 | 99,309 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,098,164 | 74,988 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,825,755 | 65,793 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,417,187 | 49,225 | Shares | Sole | 2024-05-02 | |
| 2023-09-30 | $869,883 | 26,225 | Shares | Sole | 2024-05-02 | |
| 2023-06-30 | $417,601 | 11,385 | Shares | Sole | 2024-05-02 | |
| 2023-03-31 | $107,916 | 2,645 | Shares | Sole | 2024-05-02 | |
| 2022-12-31 | $135,529 | 2,645 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $119,027 | 2,720 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $144,182 | 2,750 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $177,312 | 3,425 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,302,985 | 89,805 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,044,427 | 117,285 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,797,569 | 122,512 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,130,779 | 86,414 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $230,945 | 6,274 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $230,255 | 6,274 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $205,160 | 6,274 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $204,783 | 6,274 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||